I would reiterate in part what others said today. We're here reviewing this particular piece of legislation, CAMR, and suggested amendments to it. We generally support the bill, subject to the one clarification.
In terms of medicines, that's what the companies that I represent make: they make generic medicines, good-quality medicines from Canada, approved by Health Canada. They can contribute more to the international situation. Whether it's the Gates Foundation or the global fund, if generics are available for important medicines, then the dollars in the global fund and the Gates Foundation will go farther. I think it's complementary, so I would encourage the committee to look very seriously at this bill and look at passing some of these amendments.